Author

Emma Laing

Eli Lilly (United Kingdom)Primary ORCID profile (0000-0002-2095-2442 · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Emma LaingiD6 papers · University of Surrey

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron R. JeffriesiD· 1 shared Andrew D. RandalliD· 1 shared David Andrew CollieriD· 1 shared Eilis J. HannoniD· 1 shared Emma WalkeriD· 1 shared Hedley Baulf· 1 shared Isabel CastanhoiD· 1 shared Jonathan S. MilliD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron R. JeffriesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Transcriptional signatures of progressive neuropathology in transgenic tau and amyloid mouse models.

Isabel Castanho, Tracey K. Murray, Eilis J. Hannon, Aaron R. Jeffries, Emma Walker, Emma Laing, Hedley Baulf, Joshua Harvey, Andrew D. Randall, Karen Moore, Paul O’Neill, Katie Lunnon, David Andrew Collier, Zeshan Ahmed, Michael J. O’Neil, Jonathan S. Mill

This study identifies transcriptional changes in tau and amyloid mouse models, revealing gene expression patterns linked to AD pathology and immune response.

bioRxiv · Feb 13, 2019 · PreprintGenomics